Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | MSCI Europe Health Care 20/35 Capped |
| Investment focus | Equity, Europe, Health Care |
| Fund size | EUR 305 m |
| Total expense ratio | 0.17% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 16.33% |
| Inception/ Listing Date | 26 June 2007 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Luxembourg |
| Fund Provider | Xtrackers |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | State Street Bank International GmbH, Luxembourg Branch |
| Investment Advisor | DWS Investments UK Limited |
| Custodian Bank | State Street Bank International GmbH, Luxembourg Branch |
| Revision Company | Ernst & Young S.A. |
| Fiscal Year End | 31 December |
| Swiss representative | DWS CH AG |
| Swiss paying agent | Deutsche Bank (Suisse) SA |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | Deutsche Bank AG|Barclays Bank PLC|Société Générale|Merrill Lynch International|Goldman Sachs International|BNP Paribas|J.P. Morgan Securities plc|HSBC Bank Plc|Morgan Stanley Capital Services LLC|Citigroup Global Markets Limited |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| Roche Holding AG | 16.86% |
| Novartis AG | 15.16% |
| AstraZeneca PLC | 13.30% |
| Novo Nordisk A/S | 7.99% |
| GSK Plc | 5.51% |
| Sanofi | 5.29% |
| argenx | 3.48% |
| EssilorLuxottica SA | 3.05% |
| Bayer AG | 3.00% |
| Lonza Group AG | 2.74% |
| Switzerland | 42.92% |
| United Kingdom | 21.78% |
| Denmark | 9.78% |
| France | 9.59% |
| Other | 15.93% |
| Healthcare | 94.98% |
| Consumer Cyclicals | 3.05% |
| Business Services | 0.52% |
| Finance | 0.23% |
| Other | 1.22% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| | 0.00 € | 0.00 € | View offer** | |
| | 0.00 € | 0.00 € | View offer* | |
| | 0.00 € | 0.00 € | View offer* | |
| | 0.00 € | 0.00 € | View offer* | |
| | 0.00 € | 0.00 € | View offer* |
| Broker | Rating | Order fee | ETF savings plans | |
|---|---|---|---|---|
| | 0.00 € | 3646 | View offer** | |
| | 0.00 € | 2603 | View offer* | |
| | 0.95 € | 2530 | View offer* | |
| | 1.00 € | 2986 | View offer* | |
| | 0.00 € | 1868 | View offer* |
| YTD | -1.67% |
| 1 month | +1.23% |
| 3 months | -5.00% |
| 6 months | -1.08% |
| 1 year | +0.05% |
| 3 years | +8.16% |
| 5 years | +20.81% |
| Since inception (MAX) | +294.98% |
| 2025 | +4.06% |
| 2024 | +5.09% |
| 2023 | +10.05% |
| 2022 | -5.71% |
| Volatility 1 year | 16.33% |
| Volatility 3 years | 16.56% |
| Volatility 5 years | 15.95% |
| Return per risk 1 year | 0.00 |
| Return per risk 3 years | 0.16 |
| Return per risk 5 years | 0.24 |
| Maximum drawdown 1 year | -12.34% |
| Maximum drawdown 3 years | -27.29% |
| Maximum drawdown 5 years | -27.29% |
| Maximum drawdown since inception | -34.62% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | DXSE | - - | - - | - |
| London Stock Exchange | GBX | XSDR | XSDR LN XSDRINAV | XSDR.L XSDRNAV.DE | |
| Stuttgart Stock Exchange | EUR | DXSE | XSDR GS | XSDR.SG | |
| XETRA | EUR | DXSE | DXSE GY | DXSE.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc) | 850 | 0.18% p.a. | Accumulating | Full replication |
| State Street SPDR MSCI Europe Health Care UCITS ETF EUR | 572 | 0.18% p.a. | Accumulating | Full replication |